7th Eurasian Hematology Oncology Summit

 

7th Eurasian Hematology Oncology Summit
Avatar

2020 Frontline CML Update: Comparing TKI Inhibitors, Achieving TFR in Clinical Practice

By 7th Eurasian Hematology Oncology Summit FEATURING Giuseppe Saglio
By 7th Eurasian Hematology Oncology Summit FEATURING Giuseppe Saglio
81 views
December 11, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

13:04
Winship Cancer Institute - Emory University

Treatment-Related Quality of Life in MF

Feat. A. Hunter

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay
Leukemia
07:30
7th Eurasian Hematology Oncology Summit

Rational Drug Use for Hematologic Malignancies: How Do We Define It?…

Feat. M. Yilmaz
14:53
7th Eurasian Hematology Oncology Summit

2020 Updates on MRD in Adult ALL: How Does MRD Help With the Assessm…

Feat. F. Ravandi
12:22
7th Eurasian Hematology Oncology Summit

2020 Updates on Frontline AML: Does Midostaurin+Chemo Reduce the Ris…

Feat. G. Martinelli
23:15
7th Eurasian Hematology Oncology Summit

2020 Frontline CML Update: Comparing TKI Inhibitors, Achieving TFR i…

Feat. G. Saglio
15:13
7th Eurasian Hematology Oncology Summit

How I Treat Frontline CML in 2020: Does Imatinib Improve Long-Term S…

Feat. H. Kantarjian
14:55
7th Eurasian Hematology Oncology Summit

How I Treat Frontline ALL in 2020: Does Ph-Like Disease Have a Highe…

Feat. H. Kantarjian
17:21
7th Eurasian Hematology Oncology Summit

2020 Update on MRD in AML: Does Decitabine Prolong RFS/OS in Newly D…

Feat. F. Ravandi
14:41
7th Eurasian Hematology Oncology Summit

How I Treat AML in 2020: Is Addition of Azacitidine to Venetoclax/Pl…

Feat. F. Ravandi
21:52
7th Eurasian Hematology Oncology Summit

2020 Efficacy Data on Targeted Therapies in CLL: Do We Need to Combi…

Feat. P. Panayiotidis
18:04
7th Eurasian Hematology Oncology Summit

How I Treat CLL in 2020: How Do Ibrutinib/Rituximab & Venetoclax…

Feat. R. Foa